| Literature DB >> 6321367 |
H M Beumer, J Veldkamp, L Deleers.
Abstract
The effect of cefotaxime in treatment of lower respiratory tract infections was evaluated in 23 patients. Because of its high efficacy, low potential for adverse reactions, and convenient dosage, cefotaxime was found to be an effective antibacterial choice in the treatment of this troublesome condition.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6321367
Source DB: PubMed Journal: Int J Clin Pharmacol Ther Toxicol ISSN： 0174-4879